Yelp Inc. (NYSE:YELP) shares fell -11.27% in last trading session and ended the day at $16.06. YELP Gross Margin is 91.40% and its has a return on assets of 3.10%. Yelp Inc. (NYSE:YELP) quarterly performance is -35.89%.
Yelp Inc. (NYSE:YELP) announced that management will be attending the following investor conference. Tuesday, February 9, 2016 at 10:20 a.m. PST – Goldman Sachs Technology and Internet Conference in San Francisco, CA
China Distance Education Holdings Limited (NYSE:DL) ended the last trading day at $10.86. Company weekly volatility is calculated as 3.99% and price to cash ratio as 3.13. China Distance Education Holdings Limited (NYSE:DL) showed a weekly performance of -9.35%.
China Distance Education Holdings Limited (NYSE:DL) announced that its majority-owned subsidiary Beijing Zhengbao Yucai Education Technology Co., Ltd. (“Zhengbao Yucai”) has submitted an application to the National Equities Exchange and Quotations (“NEEQ”) to list on the New Third Board, the over-the-counter stock exchange in China.
On 08 February, Navistar International Corporation (NYSE:NAV) shares moved down -3.59% and was closed at $7.52. NAV EPS growth in last 5 year was -22.40%. Navistar International Corporation (NYSE:NAV) year to date (YTD) performance is -14.93%.
Navistar International Corporation (NYSE:NAV) said that, it is introducing its first new trucks in six years, just as Wall Street is wondering if the company that counts billionaire Carl Icahn as its biggest investor has enough cash to survive.
Xencor, Inc. (NASDAQ:XNCR) shares moved down -5.14% in last trading session and ended the day at $10.16. XNCR has a return on assets of -16.90%. Xencor, Inc. (NASDAQ:XNCR) quarterly performance is -22.44%.
Xencor, Inc. (NASDAQ:XNCR) said that, it will present Leerink Partners 5th Annual Global Healthcare Conference on 10 February.
GenVec, Inc. (NASDAQ:GNVC) caters to the Healthcare space. It has a net profit margin of -74.40% and weekly performance is -26.96%. On the last day of trading company shares ended up at $0.41. GenVec, Inc. (NASDAQ:GNVC) distance from 50-day simple moving average (SMA50) is -70.23%.
GenVec, Inc. (NASDAQ:GNVC) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Saturday, Marketbeat reports. The firm presently has a $0.50 target price on the biopharmaceutical company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 2.02% from the company’s previous close.
Leave a Reply